Dijie Li

机构：Guangxi Normal University · ORCID：0000-0003-4299-5408

发表论文 53 篇 · 总被引 1996 次 · h-index 23

代表论文

• Targeting loop3 of sclerostin preserves its cardiovascular protective action and promotes bone formation (2022 · Nature Communications · 被引 191)
• Therapeutic aptamer targeting sclerostin loop3 for promoting bone formation without increasing cardiovascular risk in osteogenesis imperfecta mice (2022 · Theranostics · 被引 90)
• Exosomal transfer of osteoclast-derived miRNAs to chondrocytes contributes to osteoarthritis progression (2021 · Nature Aging · 被引 80)
• Drug discovery of sclerostin inhibitors (2022 · Acta Pharmaceutica Sinica B · 被引 61)
• MiR-138-5p Targets MACF1 to Aggravate Aging-related Bone Loss (2022 · International Journal of Biological Sciences · 被引 47)
• miR-129-5p Inhibits Bone Formation Through TCF4 (2020 · Frontiers in Cell and Developmental Biology · 被引 39)